UBXN2A and neoplasm: In an advanced-staged tumor response approach [23], we confirmed that induction of UBXN2A can lead to more apoptotic/necrotic events during the development of stablished tumors using PSVue 794, a distinct marker of apoptosis/necrosis [24] used in live mice (Supplementary Figure S3B–S3F).